Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 34: 2058-2062, 1988;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hoek, J. A.
Right arrow Articles by Borm, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoek, J. A.
Right arrow Articles by Borm, J. J.

Clinical Chemistry, Vol 34, 2058-2062, Copyright © 1988 by American Association for Clinical Chemistry

Laboratory and clinical evaluation of an assay of thrombin-antithrombin III complexes in plasma

JA Hoek, A Sturk, JW ten Cate, RJ Lamping, F Berends and JJ Borm
Division of Hemostasis and Thrombosis, Academic Medical Center, Amsterdam, The Netherlands.

We evaluated a recently developed commercial assay for quantifying thrombin-antithrombin III (TAT) complexes in human plasma. The assay is precise (within-assay CV less than 10%, between-assay CV less than 13%), and sensitive (detection limit 0.7 micrograms of TAT per liter of plasma). Measurements for healthy volunteers yielded a normal reference (95 percentile) interval of 0.8 to 5.0 micrograms/L (n = 50, mean 2.1 micrograms/L, range 1.1 to 7.5 micrograms/L). TAT concentrations were increased in 25 of the 41 patients who fulfilled the clinical criteria of disseminated intravascular coagulation (DIC, overall mean 15.8 micrograms/L) and in 30 of the 35 patients with deep-vein thrombosis of the leg (overall mean 9.4 micrograms/L). We assessed the accuracy of the TAT assay by comparison with established criteria for the laboratory diagnosis of DIC involving various cutoff values for antithrombin III, factor V, fibrinogen, platelet count, fibrin/fibrinogen degradation products, and activated partial thromboplastin time. The low specificity of the TAT assay with regard to some of these criteria indicates that the latter are probably insensitive.


The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
R. Rej
Clinical Chemistry through Clinical Chemistry: A Journal Timeline
Clin. Chem., December 1, 2004; 50(12): 2415 - 2458.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
R C van Nieuwenhuizen, M Peters, L J Lubbers, M D Trip, J G P Tijssen, and B J M Mulder
Abnormalities in liver function and coagulation profile following the Fontan procedure
Heart, July 1, 1999; 82(1): 40 - 46.
[Abstract] [Full Text] [PDF]

Home page
 CLIN APPL THROMB HEMOSTHome page
R. Bona, A. Hickey, L. Greenwald, E. Sullivan, P. Livadiotis, O. Johnson, A. Kulak, S. Wajcs, and K. Vose
Low Risk of Subsequent Deep-Venous Thrombosis in Patients with a Negative Venous Duplex Scan
Clinical and Applied Thrombosis/Hemostasis, January 1, 1996; 2(1): 30 - 34.
[Abstract] [PDF]

Home page
 CirculationHome page
B. W. Bottiger, J. Motsch, H. Bohrer, T. Boker, M. Aulmann, P. P. Nawroth, and E. Martin
Activation of Blood Coagulation After Cardiac Arrest Is Not Balanced Adequately by Activation of Endogenous Fibrinolysis
Circulation, November 1, 1995; 92(9): 2572 - 2578.
[Abstract] [Full Text]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
B. Blauhut, W. Harringer, P. Bettelheim, J. E. Doran, P. Spath, and P. Lundsgaard-Hansen
Comparison of the effects of aprotinin and tranexamic acid on blood loss and related variables after cardiopulmonary bypass
J. Thorac. Cardiovasc. Surg., December 1, 1994; 108(6): 1083 - 1091.
[Abstract] [Full Text]

Home page
 ANGIOLOGYHome page
A. Cogo, A. Lensing, P. Prandoni, G. Canova, R. De Toni, S. Cuppini, and A. Ruol
Failure of Thrombin-Antithrombin III Complexes in the Diagnosis of Deep Vein Thrombosis
Angiology, December 1, 1992; 43(12): 975 - 979.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by the American Association for Clinical Chemistry.